TP53 and lung cancer: Other molecules which may further subdivide lung cancers include Ki67 (6), p53 (7), carcinoembryonic antigen (8), vascular endothelial growth factor (9–11), epithelial membrane antigen (11) and cytokeratin 5/6 (12), all of which have been suggested to influence disease progression and patient survival.